Published on: May 1, 2026

ELIMINATION OF CERVICAL CANCER

ELIMINATION OF CERVICAL CANCER

CONTEXT: In 2018, the World Health Organization launched a global initiative to eliminate cervical cancer, formally adopted in 2020 by 194 countries including India.

Cervical Cancer: Disease Burden and Impact

Extent of the Problem

  • Cervical cancer is the second most common cancer among women in India.
  • Around 1 lakh new cases annually and ~50,000 deaths, accounting for one-fourth of global burden.
  • Affects relatively younger women, causing high years of life lost.

Health and Social Impact

  • Causes severe physical suffering, including pain, bleeding, and organ complications.
  • Leads to emotional distress and financial hardship for families.
  • Advanced stages may cause renal failure, fistulas, and chronic pain

Prevention and Early Detection

Secondary Prevention (Screening)

  • Since the 1940s, Pap smear screening helps detect precancerous stages.
  • Cervical cancer has a long precancerous phase (10–15 years) called Cervical Intraepithelial Neoplasia (CIN).
  • Early detection allows simple and effective treatment without major surgery.

Challenges in India

  • Lack of infrastructure and trained manpower limits screening.
  • Screening coverage remains below 5%.
  • Poor follow-up and treatment compliance among women.
  • Outreach programs are insufficient compared to population needs.

HPV Vaccine: A Game Changer

Introduction of Vaccine

  • HPV vaccine introduced in 2006 for primary prevention.
  • Initially required three doses, now effective with single dose.
  • Provides 85–90% protection against cervical cancer.
  • Targets major strains HPV 16 and 18, responsible for most cases.
  • Over 500 million doses globally, ~4 million in India.
  • No serious side effects; only mild and temporary reactions.
  • No impact on fertility, reproduction, or menstrual health.

Global Success Examples

  • Countries like Australia, UK, Sweden, Denmark, Canada, USA show decline in cancer and pre-cancer cases.

Global Strategy for Elimination

WHO Targets (By 2030)

  • 90% of girls vaccinated before age 15.
  • 70% of women screened at ages 35 and 45.
  • 90% of detected cases treated.

Goal

  • Reduce incidence to less than 4 cases per 1,00,000 women.

India’s Efforts and Initiatives National HPV Vaccination Campaign (2026)

  • Launched on February 28, 2026.
  • Focus on free vaccination for adolescent girls (~14 years).
  • Demonstrates strong political commitment to women’s health.

Significance

  • Promotes preventive healthcare and awareness.
  • Aims to achieve cervical cancer-free India by 2047 (Viksit Bharat).

Key Challenges

  • Low awareness among parents and communities.
  • Limited screening coverage and healthcare access.
  • Weak last-mile delivery and follow-up systems.

Way Forward

  • Increase awareness about HPV vaccination and screening.
  • Strengthen health infrastructure and outreach programs.
  • Ensure universal access to vaccines and early diagnosis.
  • Improve compliance and monitoring systems.

Conclusion

  • Cervical cancer is largely preventable and treatable if detected early.
  • HPV vaccination + screening form the backbone of elimination strategy.
  • With strong implementation, India can achieve significant reduction in disease burden